| Stage | OKE | % of rev | CTRI | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $12.5B | 100.00% | $1.2B | 100.00% | OKE ×10.45 |
| Gross profit | $2.8B | 22.83% | $113M | 9.51% | OKE +13.3pp |
| Operating income | $1.6B | 12.59% | $61M | 5.12% | OKE +7.5pp |
| Pre-tax income | $1.4B | 10.90% | $49M | 4.09% | OKE +6.8pp |
| Net income | $1.4B | 11.11% | $27M | 2.26% | OKE +8.9pp |
| Stage | OKE | CTRI | Gap · A − B |
|---|---|---|---|
| Revenue | $12.5B100.00% | $1.2B100.00% | OKE ×10.45 |
| Gross profit | 22.83%$2.8B | 9.51%$113M | OKE +13.3pp |
| Operating income | 12.59%$1.6B | 5.12%$61M | OKE +7.5pp |
| Pre-tax income | 10.90%$1.4B | 4.09%$49M | OKE +6.8pp |
| Net income |
| 11.11%$1.4B |
| 2.26%$27M |
| OKE +8.9pp |
No shared counterparties.